This patent covers methods of screening for identifying which compounds bind to purified CD34+ cells. Since CD34+ cells are stem cells of the hematopoietic lineage, by identifying agents that bind to them it is possible to generate novel ways of purifying and identifying them.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.